ATHOS THERAPEUTICS, INC.

Profile

Company Names

ATHOS THERAPEUTICS, INC.

Addresses

1123 W. CARSON ST., TORRANCE, CA 90502

11301 OLYMPIC BLVD., SUITE 592, LOS ANGELES, CA 90064

Phone Numbers

857-222-0410
310-866-5610

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2019

State Incorporated:

DELAWARE

Total Amount Raised:

$38,255,720.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2026-04-17 
$10,282,887.00 
$20,000,000.00 
$9,717,113.00 
Debt 
2
2024-01-22 
$7,556,334.00 
$34,999,995.00 
$27,443,661.00 
Equity 
1
2021-09-15 
$20,416,499.00 
$20,416,499.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JOEL 
 
COHEN 
DIRECTOR
SOFIE BIOSCIENCES, INC.   |  ATHOS THERAPEUTICS, INC.
DIMITRIOS 
 
ILIOPOULOS 
EXECUTIVE OFFICER, DIRECTOR
PROTEAS BIOANALYTICS INC.   |  ATHOS THERAPEUTICS, INC.
CARL 
 
MCKINZIE 
DIRECTOR
TRIANGLE THERAPEUTICS INC.   |  ATHOS THERAPEUTICS, INC.   |  TRETHERA CORP
ALLAN 
J. 
PANTUCK 
EXECUTIVE OFFICER, DIRECTOR
ATHOS THERAPEUTICS, INC.
LAURENCE 
 
STEIN 
DIRECTOR
ATHOS THERAPEUTICS, INC.
ANTHONY 
 
ZINGALE 
DIRECTOR
JIVE SOFTWARE, INC.   |  CARBON BLACK, INC.   |  SERVICEMAX, INC.   |  ATHOS THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-05-15
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2026-04-17 
2024-02-06
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2024-01-22 
2021-11-17
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-09-15 
2021-09-28
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-09-15 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#